Johnson & Johnson MedTech names CFO

Johnson & Johnson MedTech named Kurt Van den Bosch as CFO.  

Advertisement

In his new role, he will provide financial leadership to the global J&J MedTech organization, according to a May 9 email to Becker’s. 

Previously, Mr. Van den Bosch was area vice president of mid-sized markets for J&J MedTech’s Europe, the Middle East and Africa regions. He joined Janssen Pharmaceuticals in Belgium in 1990.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.